id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-346711-2k736hvr	Shetty, Rohit	Stem cell therapy in COVID-19 – current evidence and future potential	2020-11-09		.txt	text/plain	3231	225	45	Acute respiratory distress syndrome (ARDS) caused by an unregulated host inflammatory response towards the viral infection, followed by multi-organ dysfunction or failure, is one of the primary causes of deaths in severe cases of COVID-19 infection. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells FDA approved mesenchymal stem cell (MSC) treatments as compassionate use in the very sickest COVID-19 patients Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial, The Lancet Therapeutic Effects of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Acute Lung Injury Mice	./cache/cord-346711-2k736hvr.txt	./txt/cord-346711-2k736hvr.txt